AKT1 and nervous system disorder: TREM2 agonists and inhibitors of the PI3K/AKT signaling pathway are being explored as potential therapeutic strategies for neurological disorders (Zhang et al., 2019; Rodriguez et al., 2020; Singh et al., 2024).